Methadone Research Unit
New Haven, Connecticut, 06519, United States
NCT Number: NCT01334580
This study involves the comparison of two treatment approaches for patients with chronic pain who are entering methadone maintenance treatment (MMT) for opioid addiction: (a) an integrated counseling that addresses both chronic pain and opioid dependence(POD)and (b) a counseling intervention that addresses opioid dependence only.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
New Haven, Connecticut, 06519, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CBT is provided by skilled psychologists in weekly sessions for 12 weeks and focuses on reducing illicit drug use and increasing pain management.
Methadone Drug Counseling (MDC)is provided by skilled drug counselors over a 12-week period. The primary goal of MDC is cessation of illicit drugs.
Time frame: 16 weeks
Time frame: 16 weeks
Time frame: 16 weeks
Time frame: 16 weeks
Yale University
Other
Comparison of Cognitive-Behavioral Therapy and Methadone Drug Counseling for Methadone-Maintained Patients With Co-occurring Chronic Pain and Opioid Dependence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04156802
Back Pain, Chemically-Induced Disorders
Winston-Salem, North Carolina, United States
View Trial DetailsNCT03681769
Back Pain, Chemically-Induced Disorders
Charleston, South Carolina, United States
View Trial DetailsNCT00634803
Chemically-Induced Disorders, Chronic Pain
New Haven, Connecticut, United States
View Trial DetailsNCT03635346
Chemically-Induced Disorders, Chronic Pain
Brest, France
View Trial Details